Association between the cytokine storm, immune cell dynamics, and viral replicative capacity in hyperacute HIV infection

Abstract

Introduction: Immunological damage in acute HIV infection (AHI) may predispose to detrimental clinical sequela. However, studies on the earliest HIV-induced immunological changes are limited, particularly in sub-Saharan Africa. We assessed the plasma cytokines kinetics, and their associations with virological and immunological parameters, in a well-characterized AHI cohort where participants were diagnosed before peak viremia. Methods: Blood cytokine levels were measured using Luminex and ELISA assays pre-infection, during the hyperacute infection phase (before or at peak viremia, 1-11 days after the first detection of viremia), after peak viremia (24-32 days), and during the early chronic phase (77-263 days). Gag-protease-driven replicative capacities of the transmitted/founder viruses were determined using a green fluorescent reporter T cell assay. Complete blood counts were determined before and immediately following AHI detection before ART initiation. Results: Untreated AHI was associated with a cytokine storm of 12 out of the 33 cytokines analyzed. Initiation of ART during Fiebig stages I-II abrogated the cytokine storm. In untreated AHI, virus replicative capacity correlated positively with IP-10 (rho = 0.84, P < 0.001) and IFN-alpha (rho = 0.59, P = 0.045) and inversely with nadir CD4 + T cell counts (rho = − 0.58, P = 0.048). Hyperacute HIV infection before the initiation of ART was associated with a transient increase in monocytes (P < 0.001), decreased lymphocytes (P = 0.011) and eosinophils (P = 0.003) at Fiebig stages I-II, and decreased eosinophils (P < 0.001) and basophils (P = 0.007) at Fiebig stages III-V. Levels of CXCL13 during the untreated hyperacute phase correlated inversely with blood eosinophils (rho = − 0.89, P < 0.001), basophils (rho = − 0.87, P = 0.001) and lymphocytes (rho = − 0.81, P = 0.005), suggesting their trafficking into tissues. In early treated individuals, time to viral load suppression correlated positively with plasma CXCL13 at the early chronic phase (rho = 0.83, P = 0.042). Conclusion: While commencement of ART during Fiebig stages I-II of AHI abrogated the HIV-induced cytokine storm, significant depletions of eosinophils, basophils, and lymphocytes, as well as transient expansions of monocytes, were still observed in these individuals in the hyperacute phase before the initiation of ART, suggesting that even ART initiated during the onset of viremia does not abrogate all HIV-induced immune changes.

Descriptive Analysis of Patients Living With HIV Affected by COVID-19

“…Early, cART can blunt the cytokine response in acute HIV infection. 14 In addition, tenofovir has been shown to have anti-inflammatory effects in cells and tissue from HIV-uninfected donors. 15 , 16 The impact on COVID-19 of ART, early therapy for SARS-CoV-2, or pre-existing immunodeficiency is unknown.…”

Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1

“…The interleukin-6 receptor antagonist Tocilizumab is described as one of the promising drugs to combat the cytokine storm [ 59 ]. The development of the cytokine storm in the patients infected by HIV-1 was shown [ 61 ].…”

Transcriptomic Biomarker Pathways Associated with Death in HIV-infected Patients with Cryptococcal Meningitis

“…3A), prior to ART commencement. Upregulation of these pathways may predispose patients to detrimental clinical sequela after ART initiation, perhaps by promoting the exaggerated in ammatory response associated with innate immune system activation in fatal C-IRIS [14,15].…”